367509-05-5

Basic information

• Product Name: (3,4-dimethoxyphenyl)(4-hydroxy-3,4-dihydroquinolin-1(2H)-yl)methanone
• Synonyms: (3,4-dimethoxyphenyl)(4-hydroxy-3,4-dihydroquinolin-1(2H)-yl)methanone
• CAS NO: 367509-05-5
• Molecular Weight: 313.353
• Mol File: 367509-05-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (3,4-dimethoxyphenyl)(4-hydroxy-3,4-dihydroquinolin-1(2H)-yl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (3,4-dimethoxyphenyl)(4-hydroxy-3,4-dihydroquinolin-1(2H)-yl)methanone(367509-05-5)
• EPA Substance Registry System: (3,4-dimethoxyphenyl)(4-hydroxy-3,4-dihydroquinolin-1(2H)-yl)methanone(367509-05-5)

Safety Data

• Hazardous Substances Data: 367509-05-5(Hazardous Substances Data)

Upstream product

• 367509-06-6 1-(3,4-dimethoxybenzoyl)-2,3-dihydroquinolin-4(1H)-one 
• 65148-06-3 N-((4-methylphenyl)sulfonyl)-N-phenyl-beta-alanine 
• 5652-38-0 N-phenyl-β-alanine 
• 4295-36-7 2,3-dihydroquinolin-4(1H)-one 
• 93-07-2 Veratric acid 

Downstream Products

• 474537-20-7 4-(tetrahydroquinolin-1-yl)-1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinoline 

Relevant articles and documents

HETEROCYCLIC COMPOUND

The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).

Soluble beta amyloid precursor protein secretion promoters

According to the present invention, there are provided compounds represented by formula (I): [wherein R1 and R2 represent hydrogen atom, a lower alkyl group, etc.; ring A is an optionally substituted benzene ring, X is oxygen atom, e